BioSpace News Archive

Acasti Pharma Inc. today announced financial and operational results for the second quarter ended September 30, 2022.

Stryker, one of the world’s leading medical technology companies, unveiled the OR of the Future—a model operating room inside Stryker’s Flower Mound facility, providing a one-of-a-kind interactive experience for customers to conceptualize new OR design and technology.

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will continue its partnership with the Cervical Spine Research Society (CSRS) as a diamond sponsor and will attend the CSRS 50th Annual Meeting held November 16 to 19 in San Diego.

UCB, a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for its investigational treatment, zilucoplan.

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the third quarter ended September 30, 2022, and provided a corporate update.

World Orphan Drug Alliance (WODA), a global alliance of full-service regional distributors for orphan drugs, welcomes Decisive Consulting into the Alliance network.

Lanier Biotherapeutics Inc. today announced that the United States Patent and Trademark Office has issued U.S. Patent 11,492,397, entitled “Neutralizing Monoclonal Antibodies to IL-25 and Uses Thereof.”

Reviva Pharmaceuticals Holdings, Inc. reported financial results for the third quarter ended September 30, 2022 and summarized recent business highlights.

Biora Therapeutics, Inc., the biotech company that is reimagining therapeutic delivery, provided a corporate update and reported financial results for the third quarter ended September 30, 2022.

Mustang Bio, Inc. announced financial results and recent corporate highlights for the third quarter ended September 30, 2022.